Currently, several anti-tumor therapies based on this mechanism have been developed, including the SLP-p53 vaccine, MVAp53 vaccine, DC-p53 vaccine and anti-p53 TCR therapy [175,176,177]. The gene discussed is TP53; the disease is neoplasm.